United Pharma IV Solutions has received three acquisition offers ranging between EGP 400 mn and 600 mn from Saudi and local investors, Al Borsa reports. According to chairman Abdallah Mahfouz, United Pharma is not looking to sell the company in its entirety, and is leaning towards expanding its shareholder base, while still maintaining the majority of shares.